부산대학교 도서관

Background & Aims The accuracy of creatinine-based estimated GFR (eGFR) in assessing the prevalence of chronic kidney disease (CKD) and associated mortality after liver transplantation (LTx) is unknown. Using measured GFR (mGFR) by iothalamate clearance, we determined the prevalence of the entire spectrum of renal dysfunction and the impact of CKD on mortality after LTx. Methods A database that prospectively tracks all LTx recipients at this academic transplant program from 1985 to 2012 was queried to identify all adult primary LTx recipients. Our post-LTx protocol incorporates GFR measurement by iothalamate clearance at regular intervals. A multistate model was used to assess the prevalence of CKD, kidney transplant, and death after LTx. Time-dependent Cox regression analysis was performed to evaluate the impact of mGFR and eGFR changes on survival. Results A total of 1211 transplant recipients were included. At the time of LTx, the median age was 54years, 60% were male and 86% were Caucasian. At 25years after LTx, 54% of patients died, 9% underwent kidney transplantation, whereas 7%, 21%, and 18% had mGFR >60, 59-30, and <30ml/min/1.73m2 respectively. The risk of death increased when mGFR decreased below 30ml/min/1.73m2: HR=2.67 (95% CI=1.80-3.96) for GFR=29-15ml/min/1.73m2 and HR=5.47 (95% CI=3.10-9.65) for GFR <15ml/min/1.73m2. Compared to mGFR, eGFR underestimated mortality risk in LTx recipients with an eGFR of 30-90ml/min/1.73m2. Conclusions An overwhelming majority of LTx recipients develop CKD. The risk of death increases exponentially when GFR <30ml/min/1.73m2. Creatinine-based eGFR underestimates the mortality risk in a large proportion of patients. [ABSTRACT FROM AUTHOR]